Now, an insulin pill, Pg14

Key Highlights:

• Researchers at Kumamoto University have developed a new method for oral insulin delivery using a peptide.
• The new method protects insulin from destruction in the digestive system, enabling it to be taken as a pill.
• The oral insulin delivery method has a pharmacological bioavailability of 33-41% compared to injections.
• Oral insulin pills have been a goal for over a century due to the inconvenience of daily injections for millions of patients.

Detailed Insights:

• The primary challenge in developing oral insulin has been the degradation of insulin in the digestive system before it can be absorbed.
• The new method uses a tiny peptide to facilitate the passage of insulin through the intestinal wall.
• Oral insulin pills require high doses, sometimes 10 times higher than injections, but this new platform reduces that requirement.
• This development could significantly improve the quality of life for individuals with diabetes who rely on insulin.

Scientific/Technical Concepts Involved:

• Insulin: A hormone that regulates blood sugar levels by allowing cells to absorb glucose.
• Peptide: A short chain of amino acids that can bind to receptors or other molecules in the body.
• Bioavailability: The proportion of a drug that enters the circulation and is able to have an active effect.